Procter & Gamble Health (BOM:500126) Cyclically Adjusted PB Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:500126 Procter & Gamble Health Ltd BOM:500126
77 GF Score
Price ₹5,506.15
GF Value ₹5,066.52
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Procter & Gamble Health Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Procter & Gamble Health  (BOM:500126) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Procter & Gamble Health Cyclically Adjusted PB Ratio Related Terms


Procter & Gamble Health Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Procter & Gamble Health's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Procter & Gamble Health Cyclically Adjusted PB Ratio Chart

Procter & Gamble Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Jun20 Jun21 Jun22 Jun23 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Procter & Gamble Health Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.60 9.70 10.25 9.20 8.02

BOM:500126 vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Procter & Gamble Health's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Procter & Gamble Health Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Procter & Gamble Health's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Procter & Gamble Health's Cyclically Adjusted PB Ratio falls into.


BOM:500126
77GF Score
Procter & Gamble Health Ltd BOM:500126
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Procter & Gamble Health Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Procter & Gamble Health's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Procter & Gamble Health's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=316.006/164.2724*164.2724
=316.006

Current CPI (Mar. 2026) = 164.2724.

Procter & Gamble Health Quarterly Data

Book Value per Share CPI Adj_Book
201509 101.753 0.000
201512 356.369 102.901 568.912
201603 102.518 0.000
201606 374.525 105.961 580.629
201609 105.961 0.000
201612 388.844 105.196 607.213
201703 105.196 0.000
201706 407.276 107.109 624.638
201709 109.021 0.000
201712 441.739 109.404 663.281
201803 109.786 0.000
201806 465.691 111.317 687.231
201809 115.142 0.000
201812 927.812 115.142 1,323.705
201903 118.202 0.000
201906 448.088 120.880 608.940
201909 123.175 0.000
201912 492.075 126.235 640.347
202003 124.705 0.000
202006 546.008 127.000 706.251
202009 130.118 0.000
202012 388.496 130.889 487.582
202103 131.771 0.000
202106 423.937 134.084 519.384
202109 135.847 0.000
202112 353.712 138.161 420.562
202203 138.822 0.000
202206 371.243 142.347 428.424
202209 144.661 0.000
202212 442.462 145.763 498.648
202303 146.865 0.000
202306 452.210 150.280 494.314
202406 324.253 155.789 341.910
202409 157.882 0.000
202412 367.761 158.323 381.581
202503 323.482 157.552 337.281
202506 159.755 0.000
202509 373.345 162.289 377.907
202512 163.281 0.000
202603 316.006 164.272 316.006

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Procter & Gamble Health (BOM:500126) Overvalued in 2026?

Based on GuruFocus' analysis, Procter & Gamble Health stock appears to be overvalued. The current stock price of ₹5,506.15 is trading 8.7% above its estimated GF Value™ of ₹5,066.52. GuruFocus considers Procter & Gamble Health to be Fairly Valued.

Key valuation signals for BOM:500126:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ₹5,066.52 vs. price of ₹5,506.15 (8.7% above fair value)
  • GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the BOM:500126 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Procter & Gamble Health Business Description

Other Exchanges PGHL:India
Address Cardinal Gracias Road, Ground Floor And First Floor, P&G Plaza, Chakala, Andheri East, Mumbai, MH, IND, 400099
Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company's distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.
77GF Score

Get the complete analysis for BOM:500126

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5,506.15
Price
₹5,066.52
GF Value